S6G5T-3

DRUG4 trials

Sponsors

Sol-Gel Technologies, Ltd.

Conditions

Acne Vulgaris

Phase 1

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

CompletedNCT04059523

Sol-Gel Technologies, Ltd.Acne Vulgaris

Start: 2019-06-27End: 2020-02-06Updated: 2020-03-18

Phase 2

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

CompletedNCT02661958

Sol-Gel Technologies, Ltd.Acne Vulgaris

Start: 2016-05-31End: 2017-10-31Updated: 2019-09-19

Phase 3

A Study of S6G5T3 in the Treatment of Acne Vulgaris

CompletedNCT03761810

Sol-Gel Technologies, Ltd.Acne Vulgaris

Start: 2018-12-14End: 2019-10-23Updated: 2021-12-16

A Study of S6G5T-3 in the Treatment of Acne Vulgaris

CompletedNCT03761784

Sol-Gel Technologies, Ltd.Acne Vulgaris

Start: 2018-12-21End: 2019-12-31Updated: 2021-12-16